Status:
ACTIVE_NOT_RECRUITING
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
Lead Sponsor:
University of Liege
Conditions:
Severe Asthma
Eligibility:
All Genders
18+ years
Brief Summary
The investigators will measure different cytokines in the sputum (interleukin ((IL))-3, granulocyte-macrophage colony-stimulating factor ((GM-CSF)), IL5, IL-13, IL-33, IL-4, IL-25 thymic stromal lymph...
Detailed Description
Severe asthma is observed in 3 to 5% of the asthmatic population and is characterized by a higher rate of exacerbations, poorly controlled asthma and/or a poor lung function. During the last ten years...
Eligibility Criteria
Inclusion
- Severe asthmatics seen in the Asthma Clinic of CHU of Liege who agree to undergo complete visit at baseline and after 6 months and 1 year of treatment with a biologic and sign informed consent.
Exclusion
- none
Key Trial Info
Start Date :
January 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2025
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04520165
Start Date
January 1 2014
End Date
August 31 2025
Last Update
October 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Liege
Liège, Liege, Belgium, 4000